Pierre-Yves Geoffard

Professeur titulaire d'une chaire à PSE

CV EN FRANÇAIS CV EN ANGLAIS
  • Directeur de recherche et co-président de l’Institutional Review Board
  • Directeur d’études
  • CNRS
  • EHESS
THÈMES DE RECHERCHE
  • Comportements individuels
  • Protection Sociale
  • Risque
  • Santé
  • Systèmes de santé
Contact

Adresse :48 boulevard Jourdan,
75014 Paris, France

Publications HAL

  • Socio-economic inequalities in access to COVID-19 tests in France in 2020: evidence from the EPICOV socio-epidemiological cohort Article dans une revue

    Testing for COVID-19 has been strongly recommended for individuals experiencing COVID-19-like symptoms or those with a close relative who tested positive. In France, tests were free of charge until mid-October 2021 and became widely available after June 2020. Our main objective was to investigate whether access to COVID-19 testing in France was associated with socio-economic conditions, considering gender and ethno-racial status. Methods A random population-based cohort survey was conducted in France in May 2020 and November 2020, including 95,388 participants aged 18 and over. We used logistic regressions to identify how having been tested in 2020 was associated with socio-economic status and exposure factors among two groups of individuals. The first group consisted of individuals who had no close relative test positive but reported experiencing Covid-19-like symptoms, such as cough, fever, dyspnea, or sudden onset of ageusia, dysgeusia, or anosmia (N=12,729). The second group included individuals, with or without symptoms, who reported that a close relative had tested positive for Covid-19 (N=5,360). Findings In both groups, testing was more frequent among individuals living in urban areas. For individuals who had no close relative test positive but reported Covid-19-like symptoms, women were 1.04 (95%CI [1.01-1.06]) more likely than men to be tested, and testing decreased with age up to 35. Individuals holding a university degree were 1.08 [1.04-1.12]) more likely than those who only completed high school to be tested, as well as those in one of the three top income deciles with reference to the bottom decile (OR 1.07, [1.02-1.13] for the top decile). Ethno-racial status was not significantly associated with testing. For respondents who had a close relative test positive, testing was strongly associated with having experienced some symptoms, especially after September 1 (OR 1.34, 95%CI [1.30-1.39]). However, there was no link between testing and income, education, or ethno-racial status. Interpretation When an individual experiences symptoms but has no close relative who is positive, the motivation to test to avoid transmitting the virus to relatives by isolating oneself is particularly strong. This strategy makes sense when there are actual possibilities to isolate, which may explain why higher income and education positively impact the propensity to test. For individuals who had a close relative test positive, most socio-economic variables were no longer related to testing once infection risk was controlled for. The availability of tests at no cost is not sufficient in itself to eliminate socio-economic inequalities in testing.

    Revue : Frontiers in Public Health

    Publié en

  • Socio-economic Inequalities in access to Covid-19 tests in France in 2020 : Evidence from the EPICOV socio-epidemiological cohort. Pré-publication, Document de travail

    Background Testing for COVID-19 has been strongly recommended for individuals experiencing COVID-19-like symptoms or those with a close relative who tested positive. In France, tests were free of charge until mid-October 2021 and became widely available after June 2020. Our main objective was to investigate whether access to COVID-19 testing in France was associated with socio-economic conditions, considering gender and ethno-racial status. Methods A random population-based cohort survey was conducted in France in May 2020 and November 2020, including 95,388 participants aged 18 and over. We used logistic regressions to identify how having been tested in 2020 was associated with socio-economic status and exposure factors among two groups of individuals. The first group consisted of individuals who had no close relative test positive but reported experiencing Covid-19-like symptoms, such as cough, fever, dyspnea, or sudden onset of ageusia, dysgeusia, or anosmia (N=12,729). The second group included individuals, with or without symptoms, who reported that a close relative had tested positive for Covid-19 (N=5,360). Findings In both groups, testing was more frequent among individuals living in urban areas. For individuals who had no close relative test positive but reported Covid-19-like symptoms, women were 1.04 (95%CI [1.01-1.06]) more likely than men to be tested, and testing decreased with age up to 35. Individuals holding a university degree were 1.08 [1.04-1.12]) more likely than those who only completed high school to be tested, as well as those in one of the three top income deciles with reference to the bottom decile (OR 1.07, [1.02-1.13] for the top decile). Ethno-racial status was not significantly associated with testing. For respondents who had a close relative test positive, testing was strongly associated with having experienced some symptoms, especially after September 1 (OR 1.34, 95%CI [1.30-1.39]). However, there was no link between testing and income, education, or ethno-racial status. Interpretation When an individual experiences symptoms but has no close relative who is positive, the motivation to test to avoid transmitting the virus to relatives by isolating oneself is particularly strong. This strategy makes sense when there are actual possibilities to isolate, which may explain why higher income and education positively impact the propensity to test. For individuals who had a close relative test positive, most socio-economic variables were no longer related to testing once infection risk was controlled for. The availability of tests at no cost is not sufficient in itself to eliminate socio-economic inequalities in testing.

    Publié en

  • Associations between anxiety and the willingness to be exposed to COVID-19 risk among French young adults during the first pandemic wave Article dans une revue

    The COVID-19 outbreak has generated significant uncertainty about the future, especially for young adults. Health and economic threats, as well as more diffuse concerns about the consequences of COVID-19, can trigger feelings of anxiety, leading individuals to adopt uncertainty-reducing behaviours. We tested whether anxiety was associated with an increase in willingness to be exposed to the risk of COVID-19 infection (WiRE) using an online survey administered to 3,110 French individuals aged between 18 and 35 years old during the first pandemic wave and lockdown period (April 2020). Overall, 56.5% of the sample declared a positive WiRE. A one standard deviation increase in psychological state anxiety raised the WiRE by +3.9 pp (95% CI [+1.6, 6.2]). Unemployment was associated with a higher WiRE (+8.2 percentage points (pp); 95% CI [+0.9, 15.4]). One standard deviation increases in perceived hospitalisation risk and in income (+1160€) were associated with a -4.1 pp (95% CI [-6.2, 2.1]) decrease in the WiRE and +2.7 pp increase (95% CI [+1.1, 4.4]), respectively. Overall, our results suggest that both psychological anxiety and the prospect of economic losses can undermine young adults’ adherence to physical distancing recommendations. Public policies targeting young adults must consider both their economic situation and their mental health, and they must use uncertainty-reducing communication strategies.

    Revue : PLoS ONE

    Publié en

Onglets

 

PSE (Paris School of Economics – Ecole d’économie de Paris) 

 

– Director (since 2013), Professor (since 2006)

– CNRS Senior Research Fellow (Directeur de recherche, since 2002) 

– Professor (Directeur d’études), Ecole des Hautes Etudes en Sciences Sociales, since 2008.

 

– Research interests : public economics,  economics of information and uncertainty, microeconomic foundations of public health policies.   


Nota : portrait ci-dessus Copyright Aurore Bagarry

 


 

Téléchargement de deux portraits haute-définition de Pierre-Yves Geoffard:

> portrait institutionnel n°1 [crédits à indiquer: Julien Benhamou]

> portrait institutionnel n°2 [crédits à indiquer: Aurore Bagarry]

> portrait institutionnel n°3 [crédits à indiquer: Aurore Bagarry]

geoffard-med-pse-2016.png

– L’accès des chercheurs aux données administratives : État des lieux et propositions d’actions(pdf – 1,9Mo) avec Antoine Bozio, Conseil national de l’information statistique, mars 2017.

– CAE-Conseil d’Analyse Economique, “Refonder l’Assurance Maladie”, Note CAE n°12 avril 2014 (avec Brigitte Dormont et Jean Tirole)

CAE-Conseil d’Analyse Economique, “Pour un système de santé plus efficace”, Note CAE n°8 juillet 2013 (avec Philippe Askenazy, Brigitte Dormont et Valérie Paris)

Les Entreprises du Médicament, International Comparison of Prices for New Drugs, 2008. (with Lluis Sauri).

Fédération Nationale de la Mutualité Française, Défense des contrats « solidaires et responsables » (argumentaire économique), 2008.

Office National d’Indemnisation des Accidents Médicaux (ONIAM), Report on «Statistical analysis of corporal damage compensation,»  2004.(with A. Chassagnon)

National Council for Evaluation, (Conseil National de l’Evaluation), Member, 2001-2003

Ministery of Health and Social Affairs (DREES, MiRe), Report on «Universal health insurance and labour market participation,»  2002. (with A. Couffinhal, P. Dourgnon, M. Grignon, Fl. Jusot, and Fl. Naudin)

Fédération Nationale de la Mutualité Française, Report on “Long-run risk management in health insurance,” 1998

Commissariat Général du Plan, Report on “Adoption rules of new drugs and growth of health expenditures,”  1998

Conseil National du Sida (National AIDS Council), Report on “HIV infection and life insurance,”  1997

Mission sida (Direction des Hôpitaux, Ministry of Public Health), Economic advisor, 1993-97, Economic analysis of hospital care for AIDS, and HIV positive, patients.

Graduate level

Price Theory I & II (Advanced Microeconomics), 24h
Ecole des Hautes Etudes en Sciences Sociales, 1995-2000
Ecole des Hautes Etudes Commerciales, University of Lausanne, 1998-2001, 2004-05
Ecole des Hautes Etudes en Sciences Sociales, 2008-…, Master APE

Health Economics (24h)
Ecole des Hautes Etudes en Sciences Sociales, 2005-…, Master APE

Health Policy (24h)
Ecole des Hautes Etudes en Sciences Sociales, 2005-…, Master PPD

Health Economics (4h), Master Erasmus Mundus « Dynamics of Health and Welfare »
Ecole des Hautes Etudes en Sciences Sociales, 2007-…,

Economic Analysis of Public Health, 8h
Institut d’Etudes Politiques de Paris, 1997-99
Ecole des Hautes Etudes en Santé Publique, 2008-09, Master of Public Health

Incentives and regulation in health care and health insurance
Institut d’économie et management de la santé, University of Lausanne, 2003-07

Economic Approach to Human Behavior (with Thierry Verdier)
Ecole des Hautes Etudes en Sciences Sociales, 1997-2001


Undergraduate level

Introduction to Economic Analysis (macro and micro)
Ecole Polytechnique, 2000-2004
Ecole normale supérieure, 1996-99.

Public Economics
Ecole Polytechnique, 2004-06.
ENSAE, 2005-07.   

Economics of Uncertainty (Finance, Insurance)
Ecole Polytechnique, 2004-06.
       

Executive training

AXA University, Risk Mastery, 2006-…
Mastery course (one week intensive programme in Risk Management),
Programme Academic Director

Institut des Actuaires, 2008-2011 (4h)
Introduction to the Economics of Risk and Uncertainty
Fédération Nationale de la Mutualité Française, 2000
The Economic analysis of health insurance (series of four lectures).

– Health Economics, Associate Editor (2009-2011)

– Expert group, Institut des Données de Santé : member (2008-2010)

– Deputy Director & Director (2005-2013) of PSE (Paris-jourdan Sciences Economiques), joint research unit CNRS-ENS-EHESS-ENPC.

– Deputy Director (1998-2004) of DELTA, joint research unit CNRS-ENS-EHESS.
   
– Head , Microsimulation project (funded by Agence Nationale de la Recherche, 2006-2009): Development and Implementation of Tax Benefit Models for France.

– Director (2006-2010) of APE (Economic Analysis and Policy) Master and Doctorate Programme (EHESS-ENS-ENPC-ENSAE-X-HEC)

CEPREMAP co-director  of the programme « Public Economics and redistribution» (2005-08)

University of Lausanne, Institut d’économie et de management de la santé.
Invited Professor (part time, 1998-2008)graduate courses in microeconomics, public economics, health economics.

Ecole Polytechnique
Associate Professor  (part time, 2000-2006) undergraduate classes in macro and microeconomics.

Caisse des dépôts et consignations, Paris (Equity Derivatives Division)
Responsable de la recherche (Research Director), 1993-94, Mathematical modeling on equity derivatives, technical support to sales.

University of Chicago (Department of Economics)
Visiting Scholar, 1992-93. Research on the economic aspects of the control of epidemics.

University of Stanford (Graduate School of Business)
Visiting Scholar, 1991-92. Research on dynamic general equilibrium theory.

  • Ph.D in Applied Mathematics, 1991.

“Recursive utility, sunspot equilibria : two intertemporal economic models.”
University Paris-IX-Dauphine, advisor : Ivar Ekeland.

  • DEA (Master’s Degree) in Economics, 1988

Ecole des Hautes Etudes en Sciences Sociales

  • DEA (Master’s Degree) in Applied Mathematics, 1987

University Paris-IX-Dauphine

  • Ecole normale supérieure, 1985-89

 

Activités non rémunérées : 

  • CEPR Research Fellow (since 1998)
  • CNIS (National Committee for Statistical Information), “Public Service and Service to the Public” Committee : president
  • Scientific committee, IRDES : member
  • Conseil National du Sida (National AIDS Committee): member
  • National Committee on Health Accounts, French Ministry of Health : member
  • Member of editorial boards, Risques, Revue Française des Affaires Sociales. Recherches Economiques de Louvain.

 

Activités rémunérées moins de 5 000 €uros par an : 

  • Libération, Rubrique « Economiques », Editorial, once every four weeks.

 

Activités rémunérées entre 5 000  et 25 000 €uros : 

  • AXA University, Risk Mastery course : Programme Academic Director
  • Collectif National des Groupements de Pharmaciens d’Officine : Membre du Comité de Pilotage